Chronic Myeloproliferative DisordersThis page contains recent news articles, when available, and an overview of Chronic Myeloproliferative Disorders but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.
News: Chronic Myeloproliferative Disorders
Earthtimes,JAK2 is the most common mutated gene in bcr-abl-negative chronic myeloproliferative disorders (MPDs). SB939, a novel histone deacetylase HDAC inhibitor with
Background information on Chronic Myeloproliferative Disorders [When available]
The myeloproliferative diseases are a group of diseases of the bone marrow where excess cells are produced. The delineation from leukemia is artificial, although the myeloproliferative diseases on the whole have a much better prognosis than the leukemias. The concept was first proposed in 1951 by the eminent hematologist William Dameshek.
The myeloproliferative diseases are:
Search the web for more resources on Chronic Myeloproliferative Disorders
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines
The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy